A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

ABSTRACT:

SUBMITTER: Tedeschi A 

PROVIDER: S-EPMC7109731 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature